07/29/2026
Manufacturers and distributors of PFAS-containing products are increasingly being sued for PFAS-related bodily injury and property damage — and even companies not yet targeted face real consequences: depressed valuations, harder access to credit, and barriers to selling the business itself.
A growing market now lets businesses address that exposure head-on: corporate liability-management transactions that transfer or sell PFAS-related liabilities off the balance sheet entirely.
This piece maps the emerging options — the benefits (valuation stability, improved access to credit) and the key legal, financial, and operational questions to weigh before pursuing one.
💡 Risk Management Insight from Haynes and Boone, LLP
Read the path to a permanent exit 👇
https://industrytoday.com/managing-pfas-risk-a-path-to-permanent-exit/